ASCO GU 2021: Talazoparib Demonstrates Durable Antitumor Activity in Metastatic Castration-Resistant Prostate Cancer
Antitumor effects were most notable in patients with BRCA1/2 alterations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.